5AM Ventures
Life sciences VC with consistent infectious-disease exposure across therapeutics and diagnostics. Life sciences VC with consistent infectious-disease exposure across therapeutics and diagnostics.
Resource Directory
AMR Funding Organizations
Connecting the right capital with the right projects
Addressing AMR requires sustained investment across the comprehensive research and development continuum, from early discovery through clinical development, commercialization, and global access. This directory maps venture capital, private equity, public agencies, philanthropic organizations, and public-private partnerships that direct capital toward the AMR response, making it easier to identify funding sources and build partnerships.
Seeking funding for your AMR project or program? Complete our Seeking Resources form, tell us about your project, and we will see if we can help.
Tell Us About Your AMR Project
Abingworth
Longstanding life sciences investor known for backing development-stage therapeutics and commercial growth stories. Longstanding life sciences investor known for backing development-stage therapeutics and commercial growth stories.
Accelerator Life Science Partners
Early-stage life-science venture and company-building firm that works closely with academic and translational founders. Early-stage life-science venture and company-building firm that works closely with academic and translational founders.
Advent Life Sciences
European venture investor focused on innovative life science companies across therapeutics and enabling technologies. European venture investor focused on innovative life science companies across therapeutics and enabling technologies.
AMR Action Fund
The AMR Action Fund is a large-scale investment initiative backed by major pharmaceutical companies to support the late-stage development of new antibiotics and bring them to market. The AMR Action Fund is a large-scale investment initiative backed by major pharmaceutical companies to support the late-stage development of new antibiotics and bring them to market.
AMR Multi-Partner Trust Fund
UN multi-partner pooled fund supporting implementation of national AMR action plans and One Health coordination with sustainable financing structures. UN multi-partner pooled fund supporting implementation of national AMR action plans and One Health coordination with sustainable financing structures.
ARCH Venture Partners
Major science-first venture firm with a strong company-creation model across breakthrough biology. Major science-first venture firm with a strong company-creation model across breakthrough biology.
ARTIS Ventures
Frontier-tech and health investor with a documented lead investment in Locus Biosciences, a precision antimicrobial company. Frontier-tech and health investor with a documented lead investment in Locus Biosciences, a precision antimicrobial company.
Atlas Venture
Company-creation biotech VC with deep scientific involvement at formation stage. Company-creation biotech VC with deep scientific involvement at formation stage.
BARDA
US government medical countermeasure funder with a dedicated antibacterial countermeasures program supporting therapeutics and diagnostics against resistant pathogens. US government medical countermeasure funder with a dedicated antibacterial countermeasures program supporting therapeutics and diagnostics against resistant pathogens.
Bill & Melinda Gates Foundation
Global health philanthropy that funds AMR-relevant diagnostics, surveillance, access, and selective therapeutic innovation, especially where global health burden is high. Global health philanthropy that funds AMR-relevant diagnostics, surveillance, access, and selective therapeutic innovation, especially where global health burden is high.
BioInnovation Institute (BII)
Danish life-science incubator and funding platform that provides early-stage capital, venture building, and infrastructure to startups, including infectious-disease and diagnostics projects. Danish life-science incubator and funding platform that provides early-stage capital, venture building, and infrastructure to startups, including infectious-disease and diagnostics projects.
Biotechnology and Biological Sciences Research Council (BBSRC)
UK research council supporting biological science, microbiology, engineering biology, and One Health work that can underpin AMR innovation. UK research council supporting biological science, microbiology, engineering biology, and One Health work that can underpin AMR innovation.
Boehringer Ingelheim Venture Fund
Corporate venture fund of Boehringer Ingelheim that explicitly includes anti-infectives / AMR as a portfolio area. Corporate venture fund of Boehringer Ingelheim that explicitly includes anti-infectives / AMR as a portfolio area.
CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator)
CARB-X is a global non-profit partnership focused exclusively on accelerating the development of new antibiotics, diagnostics, vaccines, and other products to combat antimicrobial resistance. It is funded by a coalition of governments and foundations. CARB-X is a global non-profit partnership focused exclusively on accelerating the development of new antibiotics, diagnostics, vaccines, and other products to combat antimicrobial resistance. It is funded by a coalition of governments and foundations.
CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator)
CDC Antimicrobial Resistance Investment Map / CDC
CDC funds surveillance, laboratories, and selected innovative research projects to respond to antimicrobial resistance across the public-health system. CDC funds surveillance, laboratories, and selected innovative research projects to respond to antimicrobial resistance across the public-health system.
Cystic Fibrosis Foundation Mission Ventures
Venture-philanthropy arm of the Cystic Fibrosis Foundation, relevant because CF care depends heavily on anti-infective innovation including resistant respiratory pathogens and alternative modalities. Venture-philanthropy arm of the Cystic Fibrosis Foundation, relevant because CF care depends heavily on anti-infective innovation including resistant respiratory pathogens and alternative modalities.
Deerfield Management
Healthcare investment platform with flexible financing, venture creation, and translational support across therapeutics, diagnostics, and health systems. Healthcare investment platform with flexible financing, venture creation, and translational support across therapeutics, diagnostics, and health systems.
EQT Life Sciences
Formerly LSP, one of Europe's most experienced life-science investors across therapeutics, diagnostics, and healthtech. Formerly LSP, one of Europe's most experienced life-science investors across therapeutics, diagnostics, and healthtech.
European Innovation Council / EIC Fund
EU innovation vehicle offering grants and blended finance to deep-tech and life science companies, including diagnostics and therapeutic platforms relevant to AMR. EU innovation vehicle offering grants and blended finance to deep-tech and life science companies, including diagnostics and therapeutic platforms relevant to AMR.
Stay Updated
Stay connected to keep up with the latest on antimicrobial resistance.
